| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/20/2009 | WO2009033754A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2008139261A3 Omega-3 lipid compound |
| 08/20/2009 | US20090209654 Prenylflavonoid Formulations |
| 08/20/2009 | US20090209636 Novel use of (-)-epigallocatechin gallate |
| 08/20/2009 | US20090209625 Modulation of chrebp expression |
| 08/20/2009 | US20090209613 Use of allymercaptocaptopril for treating or preventing obesity and obesity related diseases |
| 08/20/2009 | US20090209611 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 08/20/2009 | US20090209602 Chemical compounds |
| 08/20/2009 | US20090209595 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209594 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209588 Novel compounds, their preparation and use |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209568 Spiro [Benzopyran] or Spiro [Benzofuran] Derivatives Which Inhibit the Sigma Receptor |
| 08/20/2009 | US20090209564 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209544 Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 08/20/2009 | US20090209523 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) |
| 08/20/2009 | US20090209521 Inhibition of VEGF Translation |
| 08/20/2009 | US20090209510 Novel Method of Treating Hyperlipidemia |
| 08/20/2009 | US20090209492 Lipase Inhibitors |
| 08/20/2009 | US20090209486 Nutraceuticals for defense against viral diseases, infections such as traveler's diarrhea, and gastrointestinal disorders; mannose, n-acetylneuraminic acid, fucose, n-acetylgalactosamine, xylose with one of glucosamine HCL, glucosamine sulfate, galactose, or flavorings, and also e.g. honey or olive oil |
| 08/20/2009 | US20090209461 Modification of feeding behavior |
| 08/20/2009 | US20090209460 Compositions and methods for treating obesity and related metabolic disorders |
| 08/20/2009 | US20090209458 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling |
| 08/20/2009 | US20090209451 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
| 08/20/2009 | US20090209033 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity |
| 08/20/2009 | US20090208595 Extract of plant Dendrobii caulis and preparing process thereof |
| 08/20/2009 | US20090208593 Phyto aroma micro-nutritherapeutic compositions in orodietology |
| 08/20/2009 | US20090208565 Stabilized exendin-4 compounds |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208415 Tropane compounds |
| 08/20/2009 | CA2726861A1 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 08/20/2009 | CA2715386A1 Egg products with components recognized for reducing the levels of cholesterol in people and/or improving their health |
| 08/20/2009 | CA2715290A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 08/20/2009 | CA2715282A1 Indole compounds and methods of use thereof |
| 08/20/2009 | CA2714591A1 Bicycloamine derivative |
| 08/20/2009 | CA2714532A1 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 08/20/2009 | CA2714110A1 Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds and the use thereof |
| 08/20/2009 | CA2711757A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/20/2009 | CA2710862A1 A pharmaceutical composition for treating diabetes and preparation methods thereof |
| 08/19/2009 | EP2090317A1 Method of preventing or treating diabetes |
| 08/19/2009 | EP2090312A1 (S,S) reboxetine for treating attention deficit disorder |
| 08/19/2009 | EP2090177A1 Food products having enhanced cocoa polyphenol content |
| 08/19/2009 | EP2090176A1 Postprandial hyperglycemia-improving agent |
| 08/19/2009 | EP2090172A1 Dough composition |
| 08/19/2009 | EP2089389A2 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity |
| 08/19/2009 | EP2089387A1 Indolizine derivatives and their use as antidiabetics |
| 08/19/2009 | EP2089382A1 Substituted diazepan compounds as orexin receptor antagonists |
| 08/19/2009 | EP2089368A1 Diaminocyclohexane and diaminocyclopentane derivatives |
| 08/19/2009 | EP2089046A2 Antidiabetogenic calcium-peptide composition |
| 08/19/2009 | EP2089037A2 Mixture and method for reducing cholesterol using hydrophobic microparticles |
| 08/19/2009 | EP2089031A1 Reduction of overweight or obesity |
| 08/19/2009 | EP1846379B1 Antidiabetic bicyclic compounds |
| 08/19/2009 | EP1824501B1 Protein hydrolysate with antidiabetic effect |
| 08/19/2009 | EP1590334B1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | CN101511837A Pyrrolopyrimidines for pharmaceutical compositions |
| 08/19/2009 | CN101511804A Cyclic sulfones useful as mitochondrial sodium-calcium exchangers |
| 08/19/2009 | CN101511780A Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as CPT-inhibitors |
| 08/19/2009 | CN101511429A Indulines derivatives and gpr119 agonists |
| 08/19/2009 | CN101511378A Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
| 08/19/2009 | CN101511377A Lipid-metabolism-ameliorating agent |
| 08/19/2009 | CN101511371A Adhesive preparation |
| 08/19/2009 | CN101511364A Combination treatment for diabetes mellitus |
| 08/19/2009 | CN101508739A Radio frequency auxiliary method for extracting glossy ganoderma seed polysaccharide |
| 08/19/2009 | CN101508713A Glucoside containing 1,2,3-triazole structure, preparation method and application |
| 08/19/2009 | CN101508712A Glucoside containing tetrazole structure, preparation method and application |
| 08/19/2009 | CN101507800A Ludisia discolor and pumpkin composite health care product capable of reducing blood sugar and preparation method thereof |
| 08/19/2009 | CN101507796A Medicinal tea capable of treating diabetes and chronic complication thereof |
| 08/19/2009 | CN101507793A Production method of traditional Chinese medicine capable of reducing weight |
| 08/19/2009 | CN101507766A Preparation method of traditional Chinese medicine capsules with blood-fat reduction and health-care function and use thereof |
| 08/19/2009 | CN101507757A Compound Chinese medicine for treating diabetes |
| 08/19/2009 | CN101507738A Preparation method of Shu Xuening injection |
| 08/19/2009 | CN101507728A Composite for preventing and treating body acidification of diabetic |
| 08/19/2009 | CN101507727A Traditional Chinese medicine composite capable of reducing blood fat and preparation method thereof |
| 08/19/2009 | CN101507721A Postprandial hyperglycemia-improving agent |
| 08/19/2009 | CN101507719A Vitamin C film-coat preparation and preparation method thereof |
| 08/19/2009 | CN101507710A Safe selenium-complement sustained-release microspheres and preparation method thereof |
| 08/19/2009 | CN101507562A Production method of silk quilt with weight reduction and beautification function |
| 08/19/2009 | CN101507494A Special diet food for patient with hyperlipidemia and hypertension |
| 08/19/2009 | CN100529074C Therapeutic binding molecules |
| 08/19/2009 | CN100529043C Ampelopsin healthcare wine |
| 08/19/2009 | CN100528884C Phosphor isoquinolinone, derivative, synthesis method and use thereof |
| 08/19/2009 | CN100528878C Tetrahydroquinoline derivatives and a process for preparing the same |
| 08/19/2009 | CN100528864C N-substituted-2-oxodihydropyridine derivative |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/19/2009 | CN100528842C Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528237C Preparation of polynuclear iron hydroxide-sugar composite |
| 08/19/2009 | CN100528210C Health products having functions of invigorating qi and blood and restoring consciousness and refreshing oneself |
| 08/19/2009 | CN100528191C Chinese medicine preparation for treating diabetes complication and its preparing method |
| 08/19/2009 | CN100528178C Application of fatty-acid synthase inhibitor |
| 08/19/2009 | CN100528177C Red yeast preparation containing active components of glossy ganoderma and its preparation process |
| 08/19/2009 | CN100528161C Medicinal composition |
| 08/19/2009 | CN100528158C Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative |
| 08/19/2009 | CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 08/19/2009 | CN100528152C 5-hydroxymethyl -2-furol and its derivative analogue medical use |
| 08/19/2009 | CN100527991C Bitter melon antihypelipidemic bean product and its manufacturing method |
| 08/19/2009 | CN100527988C Functional component-enriched barley malt rootlets and process for producing the same |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |